Renewed certification maintains Kincardine’s role in Canopy Growth’s EU GMP flower supply chain

Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced that its Kincardine, Ontario cultivation facility ("Kincardine") has received renewed European Union Good Manufacturing Practice ("EU GMP") certification from the Regierungspräsidium Tübingen – Leitstelle Arzneimittelüberwachung Baden-Württemberg.

With its EU GMP status renewed, Canopy Growth can continue supplying Canadian-grown cannabis from Kincardine to medical cannabis markets across Europe.

Kincardine is the anchor asset of Canopy Growth’s complete end-to-end EU GMP flower supply chain, connecting Canadian cultivated flower to European distribution capabilities through Canopy Growth’s second EU GMP facility in Sankt Leon-Rot, Germany. Its renewed certification comes as the Company continues to see momentum in Europe, which helped drive a 10% year-over-year increase in international cannabis net revenue in the first quarter of fiscal 2027.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.